Ligand Completes Enrollment of Phase 1 Clinical Trial of Captisol-enabled Iohexol
Go back to Ligand Completes Enrollment of Phase 1 Clinical Trial of Captisol-enabled Iohexol| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 287.59 -4.18 (1.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $291.77 | 52 Week High | $139.79 | |||
| Open | $291.00 | 52 Week Low | $82.07 | |||
| Day High | $293.51 | P/E | 668.81 | |||
| Day Low | $284.41 | EPS | $0.43 | |||
| Volume | 247,481 | |||||
